Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Copolymer 1 inhibits experimental autoimmune uveoretinitis.

M Zhang1, C C Chan, B Vistica

  • 1National Eye Institute, NIH, Bethesda, MD 20892-1857, USA.

Journal of Neuroimmunology
|March 4, 2000
PubMed
Summary

Copolymer 1 (Cop 1) effectively inhibits experimental autoimmune uveoretinitis (EAU) in mice. This finding expands Cop 1

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alternative routes of immunization for the induction of experimental autoimmune uveoretinitis (EAU) in rodents: a comparison.

Ocular immunology and inflammation·2012
Same author

Phosphorylation of interphotoreceptor retinoid-binding protein (IRBP).

Neurochemistry international·2010
Same author

Visual cycle and its metabolic support in gecko photoreceptors.

Vision research·2006
Same author

Immune response to retinal antigens in patients with gyrate atrophy and other hereditary retinal dystrophies.

Ocular immunology and inflammation·2001
Same author

Regulation of stearoyl coenzyme A desaturase expression in human retinal pigment epithelial cells by retinoic acid.

The Journal of biological chemistry·2001
Same author

Oxidative stress induces heme oxygenase-1 immunoreactivity in Müller cells of mouse retina in organ culture.

Investigative ophthalmology & visual science·2001

Area of Science:

  • Immunology
  • Ophthalmology
  • Neuroscience

Background:

  • Copolymer 1 (Cop 1) is known to suppress experimental allergic encephalomyelitis (EAE), an autoimmune disease model.
  • Cop 1 has not been effective in other autoimmune disease models like diabetes or arthritis.
  • Experimental autoimmune uveoretinitis (EAU) is an autoimmune disease affecting the eye.

Purpose of the Study:

  • To investigate the efficacy of Cop 1 in inhibiting experimental autoimmune uveoretinitis (EAU).
  • To determine if Cop 1 can be a potential therapeutic agent for EAU.

Main Methods:

  • Induction of EAU in mice using interphotoreceptor retinoid-binding protein (IRBP).
  • Treatment of EAU-induced mice with Cop 1 at a dosage of 0.5 mg/mouse.
  • Assessment of disease severity, lymph node cell proliferation, cytokine production, and antibody response to IRBP.

Related Experiment Videos

Main Results:

  • Cop 1 treatment significantly reduced EAU disease severity by 53% (p = 0.0002).
  • Cop 1 inhibited IRBP-specific lymph node cell proliferation and cytokine production.
  • Cop 1 moderately reduced the antibody response to IRBP.

Conclusions:

  • Copolymer 1 (Cop 1) demonstrates significant efficacy in inhibiting the development of experimental autoimmune uveoretinitis (EAU).
  • Cop 1's immunomodulatory effects extend to EAU, suggesting a broader therapeutic potential than previously understood.
  • Further research into the mechanisms of Cop 1's action in EAU is warranted.